Recent Finacing
Recent Raise
Cardeas Pharma is a Seattle-based biopharma developing an inhaled amikacin/fosfomycin formulation delivered via the eFlow InLine nebulizer for treating hospital-acquired respiratory infections in mechanically ventilated patients.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
